Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Guggenheim

This Mega-Cap Stock Has the Lowest RSI—and the Most Upside

Netflix’s RSI has dropped to 33 after a post-earnings's dip, but analysts already see the selloff as overdone, with up to 35% in potential upside ahead.

MarketBeat

You’ve just stolen a priceless artifact – what happens next?

The high-profile heist at the Louvre in Paris on Oct 19, 2025, played out like a scene from a Hollywood movie: a gang of thieves steal an assortment of dazzling royal jewels on display at one of the world’s most famous museums.

The Conversation

Netflix Stock Selloff A 'Buying Opportunity': Analysts See Continued Outperformance

Netflix Inc. (NASDAQ: NFLX) analysts say they don't think the company's third-quarter results, which missed estimates, warrant too much concern. Analysts highlight the company's advertising growth as the key catalyst for its future success.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Qualcomm To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Eli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Nvidia To Rally More Than 37%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Alibaba To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth

Investors are increasingly looking to biotechnology companies for potential breakthroughs and profitable returns, as the sector shows resilience and growth amid broader market volatility. Within this landscape, Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is capturing attention with its promising drug portfolio and financial performance.

Benzinga

This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Nvidia To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

MongoDB Scores Best Day Ever After Earnings Beat—Here's What Wall Street Thinks

MongoDB Inc. (NASDAQ:MDB) is enjoying its biggest one-day rally since going public in 2017.

Benzinga

This Gap Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Benzinga

Nvidia To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Jim Cramer Says Newly Merged Paramount Skydance Is a Meme Stock. Should You Buy PSKY Here?

The newly formed Paramount Skydance's stock just earned its meme stock fame and surged. Should investors dive in or approach cautiously?

Barchart

Tesla Is Ramping Up Its Robotaxi Plans. What Does That Mean for TSLA Stock?

Tesla is reportedly looking for robotaxi employees in the New York City. Guggenheim still sees potential for a 50% crash in TSLA shares.

Benzinga

Paramount Skydance Soars on UFC White House Fight Plans and Guggenheim Buy Rating

Paramount Skydance Corporation (NASDAQ:PSKY) shares are trading higher Wednesday after Guggenheim initiated coverage on the stock with a Buy rating and a $13 price target.

Benzinga

Nvidia To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Datadog Raises Full-Year Outlook After 125+ AI Feature Launches, But OpenAI Pullback Clouds Long-Term Growth

Datadog (NASDAQ:DDOG) reported its quarterly results on Thursday.

Benzinga

AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion

On Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter 2025 sales of $15.42 billion on Thursday, beating the consensus of $14.98 billion.

Benzinga

Meta To Rally More Than 56%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Alphabet To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Benzinga

CoreWeave, Mobileye And First Solar Are Among Top 10 Large Cap Losers Last Week (July 7-July 11): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Benzinga

Datadog Stock Falls After Guggenheim Downgrade, Citing OpenAI Spending Risks

Datadog Inc (NASDAQ:DDOG) shares are trading lower Tuesday after analysts at Guggenheim downgraded the stock from Neutral to Sell, setting a new price target of $105.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations